leisure time -WSS

leisure time

author：leisure time 2025-10-01 17:19:27 - browse：25926

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Biogen says it will cut costs by $700 million, slash 1,000 jobs

WSS

In the gardens at Boston Children's Hospital, families find sanctuary

Dems pitch expanding Medicare power to negotiate drug prices

Dems pitch expanding Medicare power to negotiate drug prices

The haunting brain science of long Covid

Rise in cancer among younger people worries and puzzles doctors

The battle over 'scope creep' and who gets to be called 'doctor'

leisure time

leisure time

explore

Activists slam private health insurers over coverage restrictions

Will the FTC rein in IQVIA's health data empire?

As demand for Covid shots wanes, Moderna seeks its next success

Former reverend arrested for allegedly killing 8

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

New Alzheimer's drugs heat up race for early detection blood tests

Medicare details structure of new drug price negotiation program

Truvian presents data for its desktop blood

Medicare proposal to cover medical devices draws a mixed reaction

What it's like to live with paralysis for one psychologist

knowledge

How doctors’ personal politics affect patients

Senate panel puts off hardest PBM reforms for another day

A new crop of companies is reshaping the health data economy

Truvian presents data for its desktop blood

Roche’s Alnylam deal shows drug firms interested in heart drugs

Device maker Teleflex to acquire urology company for $600M

entertainment

hotspot

knowledge

hotspot